David P. Speert - Publications

University of British Columbia, Vancouver, Vancouver, BC, Canada 
Microbiology Biology

198 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Kennedy S, Beaudoin T, Yau YC, Caraher E, Zlosnik JE, Speert DP, LiPuma JJ, Tullis E, Waters V. Activity of tobramycin against cystic fibrosis isolates of Burkholderia cepacia complex grown as biofilms. Antimicrobial Agents and Chemotherapy. PMID 26503664 DOI: 10.1128/AAC.02068-15  0.88
2015 Driessche KV, Hens N, Tilley P, Quon BS, Chilvers MA, de Groot R, Cotton MF, Marais BJ, Speert DP, Zlosnik JE. Surgical Masks Reduce Airborne Spread of Pseudomonas aeruginosa in Colonized Patients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 192: 897-9. PMID 26426786 DOI: 10.1164/rccm.201503-0481LE  0.88
2015 Loutet SA, El-Halfawy OM, Jassem AN, López JM, Medarde AF, Speert DP, Davies JE, Valvano MA. Identification of synergists that potentiate the action of polymyxin B against Burkholderia cenocepacia. International Journal of Antimicrobial Agents. PMID 26187366 DOI: 10.1016/j.ijantimicag.2015.05.010  0.88
2015 Zlosnik JE, Zhou G, Brant R, Henry DA, Hird TJ, Mahenthiralingam E, Chilvers MA, Wilcox P, Speert DP. Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada. 30 years' experience. Annals of the American Thoracic Society. 12: 70-8. PMID 25474359 DOI: 10.1513/AnnalsATS.201408-395OC  0.88
2015 Yau YC, Ratjen F, Tullis E, Wilcox P, Freitag A, Chilvers M, Grasemann H, Zlosnik J, Speert D, Corey M, Stanojevic S, Matukas L, Leahy TR, Shih S, Waters V. Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 14: 262-6. PMID 25453872 DOI: 10.1016/J.Jcf.2014.09.013  0.88
2015 Ratjen A, Yau Y, Wettlaufer J, Matukas L, Zlosnik JE, Speert DP, LiPuma JJ, Tullis E, Waters V. In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients. Antimicrobial Agents and Chemotherapy. 59: 711-3. PMID 25348526 DOI: 10.1128/AAC.04123-14  0.88
2015 Sadarangani M, Harvey M, McDonald A, Speert DP, Dix D. Brain Abscesses Due to Aspergillus nidulans Infection during Induction Chemotherapy for Acute Lymphoblastic Leukemia Journal of Pediatric Hematology/Oncology. 37: e384-e386. DOI: 10.1097/MPH.0000000000000351  0.88
2014 Zlosnik JE, Mori PY, To D, Leung J, Hird TJ, Speert DP. Swimming motility in a longitudinal collection of clinical isolates of Burkholderia cepacia complex bacteria from people with cystic fibrosis. Plos One. 9: e106428. PMID 25203161 DOI: 10.1371/journal.pone.0106428  0.88
2014 Smolen KK, Cai B, Gelinas L, Fortuno ES, Larsen M, Speert DP, Chamekh M, Cooper PJ, Esser M, Marchant A, Kollmann TR. Single-cell analysis of innate cytokine responses to pattern recognition receptor stimulation in children across four continents. Journal of Immunology (Baltimore, Md. : 1950). 193: 3003-12. PMID 25135829 DOI: 10.4049/jimmunol.1400895  0.88
2014 Malott RJ, Wu CH, Lee TD, Hird TJ, Dalleska NF, Zlosnik JE, Newman DK, Speert DP. Fosmidomycin decreases membrane hopanoids and potentiates the effects of colistin on Burkholderia multivorans clinical isolates. Antimicrobial Agents and Chemotherapy. 58: 5211-9. PMID 24957830 DOI: 10.1128/AAC.02705-14  0.88
2014 Reikie BA, Adams RC, Leligdowicz A, Ho K, Naidoo S, Ruck CE, de Beer C, Preiser W, Cotton MF, Speert DP, Esser M, Kollmann TR. Altered innate immune development in HIV-exposed uninfected infants. Journal of Acquired Immune Deficiency Syndromes (1999). 66: 245-55. PMID 24732876 DOI: 10.1097/QAI.0000000000000161  0.88
2014 Jassem AN, Forbes CM, Speert DP. Investigation of aminoglycoside resistance inducing conditions and a putative AmrAB-OprM efflux system in Burkholderia vietnamiensis. Annals of Clinical Microbiology and Antimicrobials. 13: 2. PMID 24393536 DOI: 10.1186/1476-0711-13-2  0.88
2014 Smolen KK, Ruck CE, Fortuno ES, Ho K, Dimitriu P, Mohn WW, Speert DP, Cooper PJ, Esser M, Goetghebuer T, Marchant A, Kollmann TR. Pattern recognition receptor-mediated cytokine response in infants across 4 continents. The Journal of Allergy and Clinical Immunology. 133: 818-26.e4. PMID 24290283 DOI: 10.1016/j.jaci.2013.09.038  0.88
2013 Huse HK, Kwon T, Zlosnik JE, Speert DP, Marcotte EM, Whiteley M. Pseudomonas aeruginosa enhances production of a non-alginate exopolysaccharide during long-term colonization of the cystic fibrosis lung. Plos One. 8: e82621. PMID 24324811 DOI: 10.1371/Journal.Pone.0082621  0.88
2013 Velapatiño B, Zlosnik JE, Hird TJ, Speert DP. Total protein extraction and 2-D gel electrophoresis methods for Burkholderia species. Journal of Visualized Experiments : Jove. e50730. PMID 24192802 DOI: 10.3791/50730  0.88
2013 Dias C, McDonald A, Sincan M, Rupps R, Markello T, Salvarinova R, Santos RF, Menghrajani K, Ahaghotu C, Sutherland DP, Fortuno ES, Kollmann TR, Demos M, Friedman JM, Speert DP, et al. Recurrent subacute post-viral onset of ataxia associated with a PRF1 mutation. European Journal of Human Genetics : Ejhg. 21: 1232-9. PMID 23443029 DOI: 10.1038/ejhg.2013.20  0.88
2013 Reikie BA, Naidoo S, Ruck CE, Slogrove AL, de Beer C, la Grange H, Adams RC, Ho K, Smolen K, Speert DP, Cotton MF, Preiser W, Esser M, Kollmann TR. Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life. Clinical and Vaccine Immunology : Cvi. 20: 33-8. PMID 23114697 DOI: 10.1128/CVI.00557-12  0.88
2013 Behrends V, Ryall B, Zlosnik JE, Speert DP, Bundy JG, Williams HD. Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis chronic lung infections. Environmental Microbiology. 15: 398-408. PMID 22882524 DOI: 10.1111/j.1462-2920.2012.02840.x  0.88
2013 Kalk E, Slogrove A, Speert DP, Bettinger JA, Cotton MF, Esser M. HIV sero-conversion during late pregnancy - When to retest Southern African Journal of Hiv Medicine. 14: 90-92. DOI: 10.7196/SAJHIVMED.903  0.88
2012 Reikie BA, Adams RC, Ruck CE, Ho K, Leligdowicz A, Pillay S, Naidoo S, Fortuno ES, de Beer C, Preiser W, Cotton MF, Speert DP, Esser M, Kollmann TR. Ontogeny of Toll-like receptor mediated cytokine responses of South African infants throughout the first year of life. Plos One. 7: e44763. PMID 23028609 DOI: 10.1371/journal.pone.0044763  0.88
2012 Zlosnik JEA, Gunaratnam LC, Speert DP. Serum susceptibility in clinical isolates of Burkholderia cepacia complex bacteria: development of a growth-based assay for high throughput determination. Frontiers in Cellular and Infection Microbiology. 2: 67. PMID 22919658  0.88
2012 Waters V, Zlosnik JE, Yau YC, Speert DP, Aaron SD, Guttman DS. Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosis. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 31: 3341-50. PMID 22843295 DOI: 10.1007/S10096-012-1701-Z  0.88
2012 Slogrove A, Reikie B, Naidoo S, De Beer C, Ho K, Cotton M, Bettinger J, Speert D, Esser M, Kollmann T. HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life. Journal of Tropical Pediatrics. 58: 505-8. PMID 22555385 DOI: 10.1093/tropej/fms019  0.88
2012 Lavoie PM, Ladd M, Hirschfeld AF, Huusko J, Mahlman M, Speert DP, Hallman M, Lacaze-Masmonteil T, Turvey SE. Influence of common non-synonymous Toll-like receptor 4 polymorphisms on bronchopulmonary dysplasia and prematurity in human infants. Plos One. 7: e31351. PMID 22348075 DOI: 10.1371/journal.pone.0031351  0.88
2012 Velapatiño B, Limmathurotsakul D, Peacock SJ, Speert DP. Identification of differentially expressed proteins from Burkholderia pseudomallei isolated during primary and relapsing melioidosis. Microbes and Infection / Institut Pasteur. 14: 335-40. PMID 22172334 DOI: 10.1016/j.micinf.2011.11.011  0.88
2012 Malott RJ, Steen-Kinnaird BR, Lee TD, Speert DP. Identification of hopanoid biosynthesis genes involved in polymyxin resistance in Burkholderia multivorans. Antimicrobial Agents and Chemotherapy. 56: 464-71. PMID 22006009 DOI: 10.1128/AAC.00602-11  0.88
2011 Silva IN, Ferreira AS, Becker JD, Zlosnik JE, Speert DP, He J, Mil-Homens D, Moreira LM. Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence. Microbiology (Reading, England). 157: 3124-37. PMID 21835880 DOI: 10.1099/mic.0.050989-0  0.88
2011 Christenson K, Björkman L, Karlsson J, Sundqvist M, Movitz C, Speert DP, Dahlgren C, Bylund J. In vivo-transmigrated human neutrophils are resistant to antiapoptotic stimulation. Journal of Leukocyte Biology. 90: 1055-63. PMID 21697259 DOI: 10.1189/jlb.0111051  0.88
2011 Jassem AN, Zlosnik JE, Henry DA, Hancock RE, Ernst RK, Speert DP. In vitro susceptibility of Burkholderia vietnamiensis to aminoglycosides. Antimicrobial Agents and Chemotherapy. 55: 2256-64. PMID 21321142 DOI: 10.1128/AAC.01434-10  0.88
2011 Zlosnik JE, Costa PS, Brant R, Mori PY, Hird TJ, Fraenkel MC, Wilcox PG, Davidson AG, Speert DP. Mucoid and nonmucoid Burkholderia cepacia complex bacteria in cystic fibrosis infections. American Journal of Respiratory and Critical Care Medicine. 183: 67-72. PMID 20709823 DOI: 10.1164/rccm.201002-0203OC  0.88
2010 Picard C, von Bernuth H, Ghandil P, Chrabieh M, Levy O, Arkwright PD, McDonald D, Geha RS, Takada H, Krause JC, Creech CB, Ku CL, Ehl S, Maródi L, Al-Muhsen S, ... ... Speert DP, et al. Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine. 89: 403-25. PMID 21057262 DOI: 10.1097/MD.0b013e3181fd8ec3  0.88
2010 Lavoie PM, Huang Q, Jolette E, Whalen M, Nuyt AM, Audibert F, Speert DP, Lacaze-Masmonteil T, Soudeyns H, Kollmann TR. Profound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis. The Journal of Infectious Diseases. 202: 1754-63. PMID 20977341 DOI: 10.1086/657143  0.88
2010 Huse HK, Kwon T, Zlosnik JE, Speert DP, Marcotte EM, Whiteley M. Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo. Mbio. 1. PMID 20856824 DOI: 10.1128/Mbio.00199-10  0.88
2010 Xie F, Hu Y, Speert DP, Turvey SE, Peng G, Money DM, Magee LA, von Dadelszen P. Toll-like receptor gene polymorphisms and preeclampsia risk: a case-control study and data synthesis. Hypertension in Pregnancy. 29: 390-8. PMID 20818954 DOI: 10.3109/10641950903242659  0.88
2010 Zlosnik JE, Speert DP. The role of mucoidy in virulence of bacteria from the Burkholderia cepacia complex: a systematic proteomic and transcriptomic analysis. The Journal of Infectious Diseases. 202: 770-81. PMID 20670172 DOI: 10.1086/655663  0.88
2010 Hickey TB, Ziltener HJ, Speert DP, Stokes RW. Mycobacterium tuberculosis employs Cpn60.2 as an adhesin that binds CD43 on the macrophage surface. Cellular Microbiology. 12: 1634-47. PMID 20633027 DOI: 10.1111/j.1462-5822.2010.01496.x  0.88
2010 Brown KL, Falsafi R, Kum W, Hamill P, Gardy JL, Davidson DJ, Turvey S, Finlay BB, Speert DP, Hancock RE. Robust TLR4-induced gene expression patterns are not an accurate indicator of human immunity. Journal of Translational Medicine. 8: 6. PMID 20105294 DOI: 10.1186/1479-5876-8-6  0.88
2009 Hickey TB, Thorson LM, Speert DP, Daffé M, Stokes RW. Mycobacterium tuberculosis Cpn60.2 and DnaK are located on the bacterial surface, where Cpn60.2 facilitates efficient bacterial association with macrophages. Infection and Immunity. 77: 3389-401. PMID 19470749 DOI: 10.1128/IAI.00143-09  0.88
2009 Vanlaere E, Baldwin A, Gevers D, Henry D, De Brandt E, LiPuma JJ, Mahenthiralingam E, Speert DP, Dowson C, Vandamme P. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. International Journal of Systematic and Evolutionary Microbiology. 59: 102-11. PMID 19126732 DOI: 10.1099/Ijs.0.001123-0  0.88
2009 Eftekhar F, Speert DP. Biofilm formation by persistent and non-persistent isolates of Staphylococcus epidermidis from a neonatal intensive care unit Journal of Hospital Infection. 71: 112-116. PMID 19013672 DOI: 10.1016/j.jhin.2008.09.008  0.88
2008 Mena A, Smith EE, Burns JL, Speert DP, Moskowitz SM, Perez JL, Oliver A. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. Journal of Bacteriology. 190: 7910-7. PMID 18849421 DOI: 10.1128/JB.01147-08  0.88
2008 Brown KL, Bylund J, MacDonald KL, Song-Zhao GX, Elliott MR, Falsafi R, Hancock RE, Speert DP. ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease. Clinical Immunology (Orlando, Fla.). 129: 90-102. PMID 18676204 DOI: 10.1016/j.clim.2008.06.005  0.88
2008 MacDonald KL, Speert DP. Differential modulation of innate immune cell functions by the Burkholderia cepacia complex: Burkholderia cenocepacia but not Burkholderia multivorans disrupts maturation and induces necrosis in human dendritic cells. Cellular Microbiology. 10: 2138-49. PMID 18624797 DOI: 10.1111/j.1462-5822.2008.01197.x  0.88
2008 Vanlaere E, Lipuma JJ, Baldwin A, Henry D, De Brandt E, Mahenthiralingam E, Speert D, Dowson C, Vandamme P. Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex. International Journal of Systematic and Evolutionary Microbiology. 58: 1580-90. PMID 18599699 DOI: 10.1099/ijs.0.65634-0  0.88
2008 Zlosnik JE, Hird TJ, Fraenkel MC, Moreira LM, Henry DA, Speert DP. Differential mucoid exopolysaccharide production by members of the Burkholderia cepacia complex. Journal of Clinical Microbiology. 46: 1470-3. PMID 18256220 DOI: 10.1128/JCM.02273-07  0.88
2008 Baldwin A, Mahenthiralingam E, Drevinek P, Pope C, Waine DJ, Henry DA, Speert DP, Carter P, Vandamme P, LiPuma JJ, Dowson CG. Elucidating global epidemiology of Burkholderia multivorans in cases of cystic fibrosis by multilocus sequence typing. Journal of Clinical Microbiology. 46: 290-5. PMID 18032622 DOI: 10.1128/JCM.01818-07  0.88
2007 Turvey SE, Speert DP. Recurrent systemic pneumococcal disease and IRAK4 deficiency. The Pediatric Infectious Disease Journal. 26: 1074; author reply 1. PMID 17984826 DOI: 10.1097/INF.0b013e318156fb93  0.88
2007 Ku CL, von Bernuth H, Picard C, Zhang SY, Chang HH, Yang K, Chrabieh M, Issekutz AC, Cunningham CK, Gallin J, Holland SM, Roifman C, Ehl S, Smart J, Tang M, ... ... Speert D, et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. The Journal of Experimental Medicine. 204: 2407-22. PMID 17893200 DOI: 10.1084/jem.20070628  0.88
2007 Ernst RK, Moskowitz SM, Emerson JC, Kraig GM, Adams KN, Harvey MD, Ramsey B, Speert DP, Burns JL, Miller SI. Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis. The Journal of Infectious Diseases. 196: 1088-92. PMID 17763333 DOI: 10.1086/521367  0.88
2007 Baldwin A, Mahenthiralingam E, Drevinek P, Vandamme P, Govan JR, Waine DJ, LiPuma JJ, Chiarini L, Dalmastri C, Henry DA, Speert DP, Honeybourne D, Maiden MC, Dowson CG. Environmental Burkholderia cepacia complex isolates in human infections. Emerging Infectious Diseases. 13: 458-61. PMID 17552100 DOI: 10.3201/eid1303.060403  0.88
2007 Bylund J, MacDonald KL, Brown KL, Mydel P, Collins LV, Hancock RE, Speert DP. Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B. European Journal of Immunology. 37: 1087-96. PMID 17330823 DOI: 10.1002/eji.200636651  0.88
2007 Chung JW, Speert DP. Proteomic identification and characterization of bacterial factors associated with Burkholderia cenocepacia survival in a murine host. Microbiology (Reading, England). 153: 206-14. PMID 17185549 DOI: 10.1099/mic.0.2006/000455-0  0.88
2007 Waine DJ, Henry DA, Baldwin A, Speert DP, Honeybourne D, Mahenthiralingam E, Dowson CG. Reliability of multilocus sequence typing of the Burkholderia cepacia complex in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 6: 215-9. PMID 17141579 DOI: 10.1016/j.jcf.2006.10.003  0.88
2006 Speert DP. Bacterial infections of the lung in normal and immunodeficient patients. Novartis Foundation Symposium. 279: 42-51; disussion 51-. PMID 17278384 DOI: 10.1002/9780470035399.ch4  0.88
2006 Davidson DJ, Currie AJ, Bowdish DM, Brown KL, Rosenberger CM, Ma RC, Bylund J, Campsall PA, Puel A, Picard C, Casanova JL, Turvey SE, Hancock RE, Devon RS, Speert DP. IRAK-4 mutation (Q293X): rapid detection and characterization of defective post-transcriptional TLR/IL-1R responses in human myeloid and non-myeloid cells. Journal of Immunology (Baltimore, Md. : 1950). 177: 8202-11. PMID 17114497  0.88
2006 Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, Miller SI, Ramsey BW, Speert DP, Moskowitz SM, Burns JL, Kaul R, Olson MV. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proceedings of the National Academy of Sciences of the United States of America. 103: 8487-92. PMID 16687478 DOI: 10.1073/Pnas.0602138103  0.88
2006 Khashu M, Osiovich H, Henry D, Al Khotani A, Solimano A, Speert DP. Persistent bacteremia and severe thrombocytopenia caused by coagulase-negative Staphylococcus in a neonatal intensive care unit. Pediatrics. 117: 340-8. PMID 16452352 DOI: 10.1542/peds.2005-0333  0.88
2006 Yoon SS, Coakley R, Lau GW, Lymar SV, Gaston B, Karabulut AC, Hennigan RF, Hwang SH, Buettner G, Schurr MJ, Mortensen JE, Burns JL, Speert D, Boucher RC, Hassett DJ. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. The Journal of Clinical Investigation. 116: 436-46. PMID 16440061 DOI: 10.1172/Jci24684  0.88
2006 Bylund J, Burgess LA, Cescutti P, Ernst RK, Speert DP. Exopolysaccharides from Burkholderia cenocepacia inhibit neutrophil chemotaxis and scavenge reactive oxygen species. The Journal of Biological Chemistry. 281: 2526-32. PMID 16316987 DOI: 10.1074/jbc.M510692200  0.88
2006 Bateman E, Sheehan JK, Schoub B, Speert DP, Peiris JM, Lambrecht BN, Feldman C, Van Helden P, Brown G. Discussion Novartis Foundation Symposium. 279: 167-169.  0.88
2006 Segal A, Van Helden P, Quesniaux V, Brown G, Speert DP, Mantovani A, Hoal E, Wilkinson RJ, Bekker LG, Mizrahi V, Schoub B, McGreal E, Steinman R, Lambrecht BN, Gordon S, et al. Discussion Novartis Foundation Symposium. 279: 31-41.  0.88
2005 Baldwin A, Mahenthiralingam E, Thickett KM, Honeybourne D, Maiden MC, Govan JR, Speert DP, Lipuma JJ, Vandamme P, Dowson CG. Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. Journal of Clinical Microbiology. 43: 4665-73. PMID 16145124 DOI: 10.1128/JCM.43.9.4665-4673.2005  0.88
2005 Bylund J, Goldblatt D, Speert DP. Chronic granulomatous disease: from genetic defect to clinical presentation. Advances in Experimental Medicine and Biology. 568: 67-87. PMID 16107066 DOI: 10.1007/0-387-25342-4_5  0.88
2005 Husain E, Whitehead S, Castell A, Thomas EE, Speert DP. Viridans streptococci bacteremia in children with malignancy: relevance of species identification and penicillin susceptibility. The Pediatric Infectious Disease Journal. 24: 563-6. PMID 15933573 DOI: 10.1097/01.inf.0000164708.21464.03  0.88
2005 Lewis DA, Jones A, Parkhill J, Speert DP, Govan JR, Lipuma JJ, Lory S, Webb AK, Mahenthiralingam E. Identification of DNA markers for a transmissible Pseudomonas aeruginosa cystic fibrosis strain. American Journal of Respiratory Cell and Molecular Biology. 33: 56-64. PMID 15834046 DOI: 10.1165/rcmb.2004-0352OC  0.88
2005 Bylund J, Campsall PA, Ma RC, Conway BA, Speert DP. Burkholderia cenocepacia induces neutrophil necrosis in chronic granulomatous disease. Journal of Immunology (Baltimore, Md. : 1950). 174: 3562-9. PMID 15749893  0.88
2004 Coenye T, Henry D, Speert DP, Vandamme P. Burkholderia phenoliruptrix sp. nov., to accommodate the 2,4,5-trichlorophenoxyacetic acid and halophenol-degrading strain AC1100. Systematic and Applied Microbiology. 27: 623-7. PMID 15612618 DOI: 10.1078/0723202042369992  0.88
2004 Chu KK, MacDonald KL, Davidson DJ, Speert DP. Persistence of Burkholderia multivorans within the pulmonary macrophage in the murine lung. Infection and Immunity. 72: 6142-7. PMID 15385520 DOI: 10.1128/IAI.72.10.6142-6147.2004  0.88
2004 Conway BA, Chu KK, Bylund J, Altman E, Speert DP. Production of exopolysaccharide by Burkholderia cenocepacia results in altered cell-surface interactions and altered bacterial clearance in mice. The Journal of Infectious Diseases. 190: 957-66. PMID 15295701 DOI: 10.1086/423141  0.88
2004 Speert DP, Goldberg JB. Burkholderia cepacia complex and cystic fibrosis: in search of the smoking gun. American Journal of Respiratory and Critical Care Medicine. 170: 6-7. PMID 15220120 DOI: 10.1164/rccm.2404007  0.88
2004 Pollard AJ, Currie A, Rosenberger CM, Heale JP, Finlay BB, Speert DP. Differential post-transcriptional activation of human phagocytes by different Pseudomonas aeruginosa isolates. Cellular Microbiology. 6: 639-50. PMID 15186400 DOI: 10.1111/j.1462-5822.2004.00388.x  0.88
2004 Campsall PA, Au NH, Prendiville JS, Speert DP, Tan R, Thomas EE. Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR. Journal of Clinical Microbiology. 42: 1409-13. PMID 15070981 DOI: 10.1128/JCM.42.4.1409-1413.2004  0.88
2004 Currie AJ, Davidson DJ, Reid GS, Bharya S, MacDonald KL, Devon RS, Speert DP. Primary immunodeficiency to pneumococcal infection due to a defect in Toll-like receptor signaling. The Journal of Pediatrics. 144: 512-8. PMID 15069402 DOI: 10.1016/j.jpeds.2003.10.034  0.88
2004 Bowdish DM, Davidson DJ, Speert DP, Hancock RE. The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. Journal of Immunology (Baltimore, Md. : 1950). 172: 3758-65. PMID 15004180  0.88
2004 Davidson DJ, Currie AJ, Reid GS, Bowdish DM, MacDonald KL, Ma RC, Hancock RE, Speert DP. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. Journal of Immunology (Baltimore, Md. : 1950). 172: 1146-56. PMID 14707090  0.88
2003 Currie AJ, Speert DP, Davidson DJ. Pseudomonas aeruginosa: role in the pathogenesis of the CF lung lesion. Seminars in Respiratory and Critical Care Medicine. 24: 671-80. PMID 16088583 DOI: 10.1055/s-2004-815663  0.88
2003 Chung JW, Altman E, Beveridge TJ, Speert DP. Colonial morphology of Burkholderia cepacia complex genomovar III: implications in exopolysaccharide production, pilus expression, and persistence in the mouse. Infection and Immunity. 71: 904-9. PMID 12540572 DOI: 10.1128/IAI.71.2.904-909.2003  0.88
2002 Speert DP, Sigurs N. Short case presentations Paediatric Respiratory Reviews. 3: 273-274. PMID 12376068  0.88
2002 Speert DP. Advances in Burkholderia cepacia complex Paediatric Respiratory Reviews. 3: 230-235. PMID 12376059 DOI: 10.1016/S1526-0542(02)00185-9  0.88
2002 Speert DP, Campbell ME, Henry DA, Milner R, Taha F, Gravelle A, Davidson AG, Wong LT, Mahenthiralingam E. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. American Journal of Respiratory and Critical Care Medicine. 166: 988-93. PMID 12359659 DOI: 10.1164/rccm.2203011  0.88
2002 Pollard AJ, Probe G, Trombley C, Castell A, Whitehead S, Bigham JM, Champagne S, Isaac-Renton J, Tan R, Guiver M, Borrow R, Speert DP, Thomas E. Evaluation of a diagnostic polymerase chain reaction assay for Neisseria meningitidis in North America and field experience during an outbreak. Archives of Pathology & Laboratory Medicine. 126: 1209-15. PMID 12296761 DOI: 10.1043/0003-9985(2002)126<1209:EOADPC>2.0.CO;2  0.88
2002 Conway BA, Venu V, Speert DP. Biofilm formation and acyl homoserine lactone production in the Burkholderia cepacia complex. Journal of Bacteriology. 184: 5678-85. PMID 12270826 DOI: 10.1128/JB.184.20.5678-5685.2002  0.88
2002 Speert DP. Molecular epidemiology of Pseudomonas aeruginosa. Frontiers in Bioscience : a Journal and Virtual Library. 7: e354-61. PMID 12165481  0.88
2002 Soni R, Marks G, Henry DA, Robinson M, Moriarty C, Parsons S, Taylor P, Mahenthiralingam E, Speert DP, Bye PT. Effect of Burkholderia cepacia infection in the clinical course of patients with cystic fibrosis: a pilot study in a Sydney clinic. Respirology (Carlton, Vic.). 7: 241-5. PMID 12153690 DOI: 10.1046/j.1440-1843.2002.00387.x  0.88
2002 Hirakata Y, Srikumar R, Poole K, Gotoh N, Suematsu T, Kohno S, Kamihira S, Hancock RE, Speert DP. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. The Journal of Experimental Medicine. 196: 109-18. PMID 12093875 DOI: 10.1084/jem.20020005  0.88
2002 Vandamme P, Henry D, Coenye T, Nzula S, Vancanneyt M, LiPuma JJ, Speert DP, Govan JR, Mahenthiralingam E. Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. Fems Immunology and Medical Microbiology. 33: 143-9. PMID 12052570 DOI: 10.1016/S0928-8244(02)00301-2  0.88
2002 Chu KK, Davidson DJ, Halsey TK, Chung JW, Speert DP. Differential persistence among genomovars of the Burkholderia cepacia complex in a murine model of pulmonary infection. Infection and Immunity. 70: 2715-20. PMID 11953418 DOI: 10.1128/IAI.70.5.2715-2720.2002  0.88
2002 Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerging Infectious Diseases. 8: 181-7. PMID 11897071 DOI: 10.3201/eid0802.010163  0.88
2002 Greenberg D, Speert DP, Mahenthiralingam E, Henry DA, Campbell ME, Scheifele DW. Emergence of penicillin-nonsusceptible Streptococcus pneumoniae invasive clones in Canada. Journal of Clinical Microbiology. 40: 68-74. PMID 11773094 DOI: 10.1128/JCM.40.1.68-74.2002  0.88
2001 Mahenthiralingam E, Vandamme P, Campbell ME, Henry DA, Gravelle AM, Wong LT, Davidson AG, Wilcox PG, Nakielna B, Speert DP. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 33: 1469-75. PMID 11588691 DOI: 10.1086/322684  0.88
2001 Chiu CH, Wong S, Hancock REW, Speert DP. Adherence of Burkholderia cepacia to respiratory tract epithelial cells and inhibition with dextrans Microbiology. 147: 2651-2658. PMID 11577144  0.88
2001 Coenye T, Mahenthiralingam E, Henry D, LiPuma JJ, Laevens S, Gillis M, Speert DP, Vandamme P. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates International Journal of Systematic and Evolutionary Microbiology. 51: 1481-1490. PMID 11491349  0.88
2001 Chiu CH, Ostry A, Speert DP. Invasion of murine respiratory epithelial cells in vivo by Burkholderia cepacia Journal of Medical Microbiology. 50: 594-601. PMID 11444769  0.88
2001 Pollard AJ, Heale JP, Tsang A, Massing B, Speert DP. Nonopsonic phagocytosis of Pseudomonas aeruginosa: Insights from an infant with leukocyte adhesion deficiency Pediatric Infectious Disease Journal. 20: 452-454. PMID 11332677 DOI: 10.1097/00006454-200104000-00019  0.88
2001 Coenye T, LiPuma JJ, Henry D, Hoste B, Vandemeulebroeke K, Gillis M, Speert DP, Vandamme P. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients International Journal of Systematic and Evolutionary Microbiology. 51: 271-279. PMID 11321071  0.88
2001 Heale JP, Pollard AJ, Stokes RW, Simpson D, Tsang A, Massing B, Speert DP. Two distinct receptors mediate nonopsonic phagocytosis of different strains of Pseudomonas aeruginosa. The Journal of Infectious Diseases. 183: 1214-20. PMID 11262203 DOI: 10.1086/319685  0.88
2001 Henry DA, Mahenthiralingam E, Vandamme P, Coenye T, Speert DP. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex Journal of Clinical Microbiology. 39: 1073-1078. PMID 11230429 DOI: 10.1128/JCM.39.3.1073-1078.2001  0.88
2001 Heale JP, Speert DP. Protein kinase C agonists enhance phagocytosis of P. aeruginosa by murine alveolar macrophages Journal of Leukocyte Biology. 69: 158-160. PMID 11200060  0.88
2001 Speert DP. Understanding Burholderia cepacia: Epidemiology, genomovars, and virulence Infections in Medicine. 18: 49-56.  0.88
2000 Hancock RE, Speert DP. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 3: 247-255. PMID 11498392 DOI: 10.1054/drup.2000.0152  0.88
2000 Campbell M, Mahenthiralingam E, Speert DP. Evaluation of random amplified polymorphic DNA typing of Pseudomonas aeruginosa Journal of Clinical Microbiology. 38: 4614-4615. PMID 11101604  0.88
2000 Saiman L, MacDonald N, Burns JL, Hoiby N, Speert DP, Weber D. Infection control in cystic fibrosis: Practical recommendations for the hospital, clinic, and social settings American Journal of Infection Control. 28: 381-385. PMID 11029140 DOI: 10.1067/Mic.2000.106337  0.88
2000 Cheung DOY, Halsey K, Speert DP. Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa Infection and Immunity. 68: 4585-4592. PMID 10899859 DOI: 10.1128/IAI.68.8.4585-4592.2000  0.88
2000 Simpson DA, Speert DP. RpmA is required for nonopsonic phagocytosis of Pseudomonas aeruginosa Infection and Immunity. 68: 2493-2502. PMID 10768936 DOI: 10.1128/IAI.68.5.2493-2502.2000  0.88
2000 Aaron SD, Ferris W, Henry DA, Speert DP, MacDonald NE. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia American Journal of Respiratory and Critical Care Medicine. 161: 1206-1212. PMID 10764313  0.88
2000 Vandamme P, Mahenthiralingam E, Holmes B, Coenye T, Hoste B, De Vos P, Henry D, Speert DP. Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV). Journal of Clinical Microbiology. 38: 1042-7. PMID 10698993  0.88
2000 Hirakata Y, Finlay BB, Simpson DA, Kohno S, Kamihira S, Speert DP. Penetration of clinical isolates of Pseudomonas aeruginosa through MDCK epithelial cell monolayers Journal of Infectious Diseases. 181: 765-769. PMID 10669373 DOI: 10.1086/315276  0.88
2000 Mahenthiralingam E, Coenye T, Chung JW, Speert DP, Govan JR, Taylor P, Vandamme P. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. Journal of Clinical Microbiology. 38: 910-3. PMID 10655415  0.88
2000 Finlay WH, Lange CF, King M, Speert DP. Lung delivery of aerosolized dextran American Journal of Respiratory and Critical Care Medicine. 161: 91-97. PMID 10619803  0.88
1999 Speert DP, Steen B, Halsey K, Kwan E. A murine model for infection with Burkholderia cepacia with sustained persistence in the spleen Infection and Immunity. 67: 4027-4032. PMID 10417170  0.88
1999 Bryan R, Feldman M, Jawetz SC, Rajan S, DiMango E, Tang HB, Scheffler L, Speert DP, Prince A. The effects of aerosolized dextran in a mouse model of Pseudomonas aeruginosa pulmonary infection Journal of Infectious Diseases. 179: 1449-1458. PMID 10228067 DOI: 10.1086/314755  0.88
1999 Wong SYC, Guerdoud LM, Cantin A, Speert DP. Glucose stimulates phagocytosis of unopsonized Pseudomonas aeruginosa by cultivated human alveolar macrophages Infection and Immunity. 67: 16-21. PMID 9864190  0.88
1998 Stokes RW, Thorson LM, Speert DP. Nonopsonic and opsonic association of Mycobacterium tuberculosis with resident alveolar macrophages is inefficient. Journal of Immunology (Baltimore, Md. : 1950). 160: 5514-21. PMID 9605155  0.88
1998 Feng W, Garrett H, Speert DP, King M. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro American Journal of Respiratory and Critical Care Medicine. 157: 710-714. PMID 9517580  0.88
1998 Speert DP. Group A streptococcal carriage: Can the troll be tamed? Canadian Journal of Infectious Diseases. 9: 205-206.  0.88
1998 Speert DP, King M, Finlay W. Treatment of lung infection: Colonization blockers Pediatric Pulmonology. 26: 188-189.  0.88
1997 Speert DP, Wong SY, Macdonald M, Sargeant R. Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosa Behring Institute Mitteilungen. 274-282. PMID 9382751  0.88
1997 Woods DE, Lam JS, Paranchych W, Speert DP, Campbell M, Godfrey AJ. Correlation of Pseudomonas aeruginosa virulence factors from clinical and environmental isolates with pathogenicity in the neutropenic mouse Canadian Journal of Microbiology. 43: 541-551. PMID 9226874  0.88
1997 Dohil M, Prendiville JS, Crawford RI, Speert DP. Cutaneous manifestations of chronic granulomatous disease: A report of four cases and review of the literature Journal of the American Academy of Dermatology. 36: 899-907. PMID 9204051 DOI: 10.1016/S0190-9622(97)80269-1  0.88
1997 Mahenthiralingam E, Simpson DA, Speert DP. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis Journal of Clinical Microbiology. 35: 808-816. PMID 9157133  0.88
1997 Henry DA, Campbell ME, LiPuma JJ, Speert DP. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. Journal of Clinical Microbiology. 35: 614-9. PMID 9041399  0.88
1996 Barghouthi S, Guerdoud LM, Speert DP. Inhibition by dextran of Pseudomonas aeruginosa adherence to epithelial cells American Journal of Respiratory and Critical Care Medicine. 154: 1788-1793. PMID 8970372  0.88
1996 Mahenthiralingam E, Campbell ME, Henry DA, Speert DP. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. Journal of Clinical Microbiology. 34: 2914-20. PMID 8940422  0.88
1996 Davies HD, Langley JM, Speert DP. Rating authors' contributions to collaborative research: The PICNIC survey of university departments of pediatrics Cmaj. 155: 877-882. PMID 8837534  0.88
1996 Mahenthiralingam E, Campbell ME, Foster J, Lam JS, Speert DP. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. Journal of Clinical Microbiology. 34: 1129-35. PMID 8727889  0.88
1996 Everett KD, Barghouthi S, Speert DP. In vitro culture of murine peritoneal and alveolar macrophages modulates phagocytosis of Pseudomonas aeruginosa and glucose transport. Journal of Leukocyte Biology. 59: 539-44. PMID 8613702  0.88
1996 Cham BP, Rogers PC, Chan KW, Speert DP. Neutrophil function in pediatric patients after bone marrow transplantation International Journal of Pediatric Hematology/Oncology. 3: 75-82.  0.88
1996 Hall M, MacDonald NE, Albritton W, Boucher F, Delage G, Ford-Jones E, King S, Speert DP. Varicella zoster immune globulin use in neonates and infants Canadian Journal of Infectious Diseases. 7: 17-18.  0.88
1995 Barghouthi S, Everett KD, Speert DP. Nonopsonic phagocytosis of Pseudomonas aeruginosa requires facilitated transport of D-glucose by macrophages. Journal of Immunology (Baltimore, Md. : 1950). 154: 3420-8. PMID 7897223  0.88
1995 Stokes RW, Speert DP. Lipoarabinomannan inhibits nonopsonic binding of Mycobacterium tuberculosis to murine macrophages. Journal of Immunology (Baltimore, Md. : 1950). 155: 1361-9. PMID 7636201  0.88
1995 Marklund BI, Speert DP, Stokes RW. Gene replacement through homologous recombination in Mycobacterium intracellulare. Journal of Bacteriology. 177: 6100-5. PMID 7592373  0.88
1995 Mahenthiralingam E, Speert DP. Nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages and polymorphonuclear leukocytes requires the presence of the bacterial flagellum Infection and Immunity. 63: 4519-4523. PMID 7591095  0.88
1995 Burdge DR, Noble MA, Campbell ME, Krell VL, Speert DP. Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 20: 445-8. PMID 7537977 DOI: 10.1093/clinids/20.2.445  0.88
1995 Mahenthiralingam E, Campbell M, Speert DP, Govan JRW, LiPuma JJ, Stull TL, Steinbach SF, Goldstein R. Burkholderia cepacia in cystic fibrosis [1] New England Journal of Medicine. 332: 819-821. PMID 7532284 DOI: 10.1056/NEJM199503233321213  0.88
1995 Speert DP. The use of Bacille Calmette-Guerin vaccination in children Canadian Journal of Infectious Diseases. 6: 232-233.  0.88
1995 Albritton W, Boucher F, Delage G, Ford-Jones E, Hall M, King S, MacDonald N, Speert DP. Poststreptococcal arthritis Canadian Journal of Infectious Diseases. 6: 133-135.  0.88
1995 Hall M, Halperin SA, Walton I, Albritton W, Boucher F, Delage G, Ford-Jones E, King S, Speert DP, Friesen FR, Gold R, Marchessault V, Carlson J, Pickering L, Waters J. Update: Intravenous immune globulin in children Canadian Journal of Infectious Diseases. 6: 11-13.  0.88
1994 Mahenthiralingam E, Campbell ME, Speert DP. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infection and Immunity. 62: 596-605. PMID 8300217  0.88
1994 Dasgupta T, De Kievit TR, Masoud H, Altman E, Richards JC, Sadovskaya I, Speert DP, Lam JS. Characterization of lipopolysaccharide-deficient mutants of Pseudomonas aeruginosa derived from serotypes O3, O5, and O6 Infection and Immunity. 62: 809-817. PMID 8112851  0.88
1994 Rest RF, Speert DP. Measurement of nonopsonic phagocytic killing by human and mouse phagocytes Methods in Enzymology. 236: 91-108. PMID 7968642 DOI: 10.1016/0076-6879(94)36010-3  0.88
1994 Speert DP, Bond M, Woodman RC, Curnutte JT. Infection with pseudomonas cepacia in chronic granulomatous disease: Role of nonoxidative killing by neutrophils in host defense Journal of Infectious Diseases. 170: 1524-1531. PMID 7527826 DOI: 10.1093/infdis/170.6.1524  0.88
1994 Speert DP. Infection control issues for patients with cystic fibrosis Report On Pediatric Infectious Diseases. 4: 15-16.  0.88
1994 Hall M, MacDonald NE, Albritton W, Boucher F, Delage G, Ford-Jones E, King S, Speert DP. Should there be routine testing for human immunodeficiency virus infection in pregnancy? Canadian Journal of Infectious Diseases. 5: 203-204.  0.88
1993 Speert DP, Campbell ME, Davidson AG, Wong LT. Pseudomonas aeruginosa colonization of the gastrointestinal tract in patients with cystic fibrosis. The Journal of Infectious Diseases. 167: 226-9. PMID 8418173 DOI: 10.1093/infdis/167.1.226  0.88
1993 Stokes RW, Haidl ID, Jefferies WA, Speert DP. Mycobacteria-macrophage interactions. Macrophage phenotype determines the nonopsonic binding of Mycobacterium tuberculosis to murine macrophages. Journal of Immunology (Baltimore, Md. : 1950). 151: 7067-76. PMID 8258711  0.88
1993 Speert DP. Phagocytosis of Pseudomonas aeruginosa by macrophages: receptor-ligand interactions Trends in Microbiology. 1: 217-221. PMID 8137118 DOI: 10.1016/0966-842X(93)90135-E  0.88
1993 Speert DP, LiPuma J, Ogle JW. Cystic fibrosis camps. The Pediatric Infectious Disease Journal. 12: 789. PMID 7692380  0.88
1992 Finlay JC, Speert DP. Sylvatic hydatid disease in children: case reports and review of endemic Echinococcus granulosus infection in Canada and Alaska. The Pediatric Infectious Disease Journal. 11: 322-6. PMID 1565558  0.88
1992 Speert DP, Gordon S. Phagocytosis of unopsonized Pseudomonas aeruginosa by murine macrophages is a two-step process requiring glucose Journal of Clinical Investigation. 90: 1085-1092. PMID 1522217  0.88
1991 Phillips P, Forbes JC, Speert DP. Disseminated infection with Pseudallescheria boydii in a patient with chronic granulomatous disease: Response to gamma–interferon plus antifungal chemotherapy Pediatric Infectious Disease Journal. 10: 536-539. PMID 1908570  0.88
1991 Bayer AS, Speert DP, Park S, Tu J, Witt M, Nast CC, Norman DC. Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa Infection and Immunity. 59: 302-308. PMID 1898898  0.88
1991 Conly ME, Speert DP. Human neonatal Monocyte-Derived macrophages and neutrophils exhibit normal nonopsonic and opsonic receptor-mediated phagocytosis and superoxide anion production Biology of the Neonate. 60: 361-366. PMID 1665710  0.88
1991 Wilson E, Thorson L, Speert DP. Enhancement of macrophage superoxide anion production by amphotericin B Antimicrobial Agents and Chemotherapy. 35: 796-800. PMID 1649568  0.88
1991 Speert DP, Thorson L. Suppression by human recombinant gamma interferon of in vitro macrophage nonopsonic and opsonic phagocytosis and killing Infection and Immunity. 59: 1893-1898. PMID 1645327  0.88
1991 Speert DP. Phenotypic conversion of Pseudomonas aeruginosa (Reply) Journal of Clinical Microbiology. 29: 417.  0.88
1990 Pike MG, Wong PKH, Bencivenga R, Flodmark O, Cabral DA, Speert DP, Farrell K. Electrophysiologic studies, computed tomography, and neurologic outcome in acute bacterial meningitis The Journal of Pediatrics. 116: 702-706. PMID 2329418 DOI: 10.1016/S0022-3476(05)82651-4  0.88
1990 Bayer AS, Eftekhar F, Tu J, Nast CC, Speert DP. Oxygen-dependent up-regulation of mucoid exopolysaccharide (alginate) production in Pseudomonas aeruginosa Infection and Immunity. 58: 1344-1349. PMID 2139011  0.88
1990 Speert DP, Farmer SW, Campbell ME, Musser JM, Selander RK, Kuo S. Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis. Journal of Clinical Microbiology. 28: 188-94. PMID 2107198  0.88
1989 Speert DP, Davidson AGF, Wong LTK, Paranchych W. Communicability of Pseudomonas infections in patients with cystic fibrosis The Journal of Pediatrics. 114: 1068-1069. PMID 2723904 DOI: 10.1016/S0022-3476(89)80476-7  0.88
1989 Speert DP, Campbell ME, Farmer SW, Volpel K, Joffe AM, Paranchych W. Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa. Journal of Clinical Microbiology. 27: 2589-93. PMID 2572604  0.88
1989 Speert DP. Prevention of severe lower respiratory infections in patients with cystic fibrosis Seminars in Respiratory Infections. 4: 266-271. PMID 2516638  0.88
1988 Campbell ME, Farmer SW, Speert DP. New selective medium for Pseudomonas aeruginosa with phenanthroline and 9-chloro-9-[4-(diethylamino)phenyl]-9,10-dihydro-10- phenylacridine hydrochloride (C-390). Journal of Clinical Microbiology. 26: 1910-2. PMID 3141474  0.88
1988 Eftekhar F, Speert DP. Alginase treatment of mucoid Pseudomonas aeruginosa enhances phagocytosis by human monocyte-derived macrophages Infection and Immunity. 56: 2788-2793. PMID 3139564  0.88
1988 Speert DP, Wright SD, Silverstein SC, Mah B. Functional characterization of macrophage receptors for in vitro phagocytosis of unopsonized Pseudomonas aeruginosa. The Journal of Clinical Investigation. 82: 872-9. PMID 3138287 DOI: 10.1172/JCI113692  0.88
1988 Grant Stiver H, Zachidniak K, Speert DP. Inhibition of polymorphonuclear leukocyte chemotaxis by the mucoid exopolysaccharide of Pseudomonas aeruginosa Clinical and Investigative Medicine. 11: 247-252. PMID 2971496  0.88
1988 Pasloske BL, Joffe AM, Sun Q, Volpel K, Paranchych W, Eftekhar F, Speert DP. Serial isolates of Pseudomonas aeruginosa from a cystic fibrosis patient have identical pilin sequences Infection and Immunity. 56: 665-672. PMID 2893774  0.88
1988 Lam JS, MacDonald LA, Kropinski AM, Speert DP. Characterization of non-typable strains of Pseudomonas aeruginosa from cystic fibrosis patients by means of monoclonal antibodies and SDS-polyacrylamide gel electrophoresis Serodiagnosis and Immunotherapy in Infectious Disease. 2: 365-374. DOI: 10.1016/0888-0786(88)90064-9  0.88
1987 Cabral DA, Flodmark O, Farrell K, Speert DP. Prospective study of computed tomography in acute bacterial meningitis The Journal of Pediatrics. 111: 201-205. PMID 3612390 DOI: 10.1016/S0022-3476(87)80067-7  0.88
1987 Speert DP, Dimmick JE, Pier GB, Saunders JM, Hancock REW, Kelly N. An immunohistological evaluation of Pseudomonas aeruginosa pulmonary infection in two patients with cystic fibrosis Pediatric Research. 22: 743-747. PMID 3431961  0.88
1987 Battershill JL, Speert DP, Hancock REW. Use of monoclonal antibodies to protein F of Pseudomonas aeruginosa as opsonins for phagocytosis by macrophages Infection and Immunity. 55: 2531-2533. PMID 3115901  0.88
1987 Pier GB, Saunders JM, Ames P, Edwards MS, Auerbach H, Goldfarb J, Speert DP, Hurwitch S. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis New England Journal of Medicine. 317: 793-798. PMID 2957591  0.88
1987 Cabral DA, Loh BA, Speert DP. Mucoid pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages Pediatric Research. 22: 429-431. PMID 2891100  0.88
1987 Speert DP, Campbell ME. Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis. The Journal of Hospital Infection. 9: 11-21. PMID 2880893 DOI: 10.1016/0195-6701(87)90089-2  0.88
1986 Pier GB, Desjardins D, Aguilar T, Barnard M, Speert DP. Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients Journal of Clinical Microbiology. 24: 189-196. PMID 2943759  0.88
1986 Paranchych W, Sastry PA, Volpel K, Loh BA, Speert DP. Fimbriae (PILI): Molecular basis of Pseudomonas aeruginosa adherence Clinical and Investigative Medicine. 9: 113-118. PMID 2873911  0.88
1986 Speert DP, Loh BA, Cabral DA, Salit IE. Nonopsonic phagocytosis of nonmucoid Pseudomonas aeruginosa by human neutrophils and monocyte-derived macrophages is correlated with bacterial piliation and hydrophobicity Infection and Immunity. 53: 207-212. PMID 2873104  0.88
1985 Burdge DR, Scheifele D, Speert DP. Serious Pasteurella multocida Infections From Lion and Tiger Bites Jama: the Journal of the American Medical Association. 253: 3296-3297. PMID 3999316 DOI: 10.1001/jama.1985.03350460096030  0.88
1985 Cabral DA, Johnson HW, Coleman GU, Nigro M, Speert DP. Tuberculous epididymitis as a cause of testicular pseudomalignancy in two young children Pediatric Infectious Disease. 4: 59-62. PMID 3969366  0.88
1985 Speert DP. Host defenses in patients with cystic fibrosis: modulation by Pseudomonas aeruginosa Survey and Synthesis of Pathology Research. 4: 14-33. PMID 3927464  0.88
1985 Speert DP, Loh BA, Cabral DA, Eftekhar F. Opsonin-independent phagocytosis of Pseudomonas aeruginosa Antibiotics and Chemotherapy. 36: 88-94. PMID 3923915  0.88
1985 Speert DP, Silverstein SC. Phagocytosis of unopsonized zymosan by human monocyte-derived macrophages: Maturation and inhibition by mannan Journal of Leukocyte Biology. 38: 655-658. PMID 3862731  0.88
1984 Murray AB, Laxer RM, Petty RE, Speert DP. Role of house dust mites in Kawasaki disease Canadian Medical Association Journal. 131: 720. PMID 6478359  0.88
1984 Hancock REW, Mouat ECA, Speert DP. Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis Journal of Infectious Diseases. 149: 220-226. PMID 6421943  0.88
1984 Speert DP, Eftekhar F, Puterman ML. Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients Infection and Immunity. 43: 1006-1011. PMID 6421734  0.88
1984 Speert DP, Lawton D, Mutharia LM. Antibody to pseudomonas aeruginosa mucoid exopolysaccharide and to sodium alginate in cystic fibrosis serum Pediatric Research. 18: 431-433. PMID 6233529  0.88
1983 Hancock REW, Mutharia LM, Chan L, Darveau RP, Speert DP, Pier GB. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: A class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains Infection and Immunity. 42: 170-177. PMID 6413410  0.88
1982 Speert DP, Lawton D, Damm S. Communicability of Pseudomonas aeruginosa in a cystic fibrosis summer camp The Journal of Pediatrics. 101: 227-229. PMID 6808106 DOI: 10.1016/S0022-3476(82)80127-3  0.88
1982 Speert DP, Wannamaker LW, Quie PG. Reply Journal of Infectious Diseases. 146: 577-578. DOI: 10.1093/infdis/146.4.577  0.88
1981 Speert DP, Quie PG, Wannamaker LW. Enhanced phagocytosis of group A streptococci M type 6 by oleic acid. The Journal of Infectious Diseases. 143: 570-7. PMID 7017016 DOI: 10.1093/infdis/143.4.570  0.88
1981 Johnson DE, Bass JL, Thompson TR, Foker JE, Speert DP, Kaplan EL. Candida Septicemia and Right Atrial Mass Secondary to Umbilical Vein Catheterization American Journal of Diseases of Children. 135: 275-277. PMID 6782858 DOI: 10.1001/archpedi.1981.02130270067024  0.88
1980 Speert DP, Munson D, Mitchell C, Johnson DE, Thompson TR, Ferrieri P, Wannamaker LW. Mycobacterium chelonei septicemia in a premature infant. The Journal of Pediatrics. 96: 681-3. PMID 7359272 DOI: 10.1016/S0022-3476(80)80739-6  0.88
1980 Speert DP, Wannamaker LW. Susceptibility of group A streptococci to oleic acid and ultraviolet light. Comparison of strains from throat and skin. The Journal of Laboratory and Clinical Medicine. 96: 252-7. PMID 6995539  0.88
1979 Speert DP, Britt WJ, Kaplan EL. Tick-Borne Tularemia Presenting as Ulcerative Lymphadenitis Clinical Pediatrics. 18: 239-241. PMID 428180 DOI: 10.1177/000992287901800408  0.88
1979 Speert DP, Wannamaker LW, Gray ED, Clawson CC. Bactericidal effect of oleic acid on group A streptococci: mechanism of action. Infection and Immunity. 26: 1202-10. PMID 393631 DOI: 10.1128/Iai.26.3.1202-1210.1979  0.88
1979 Ancona RJ, McAuliffe J, Thompson TR, Speert DP, Ferrieri P. Group B streptococcal sepsis with osteomyelitis and arthritis. Its occurrence with acute heart failure. American Journal of Diseases of Children (1960). 133: 919-20. PMID 382836 DOI: 10.1001/archpedi.1979.02130090047008  0.88
1978 Magilavy DB, Speert DP, Silver TM, Sullivan DB. Mucocutaneous lymph node syndrome: report of two cases complicated by gallbladder hydrops and diagnosed by ultrasound. Pediatrics. 61: 699-702. PMID 662507  0.88
1978 Speert DP, Silva J. Abnormalities of In Vitro Lymphocyte Response to Mitogens in Diabetic Children During Acute Ketoacidosis American Journal of Diseases of Children. 132: 1014-1017. PMID 102185 DOI: 10.1001/archpedi.1978.02120350078016  0.88
1977 Steffensen DM, Chu EHY, Speert DP, Wall PM, Meilinger K, Kelch RP. Partial trisomy of the long arm of human chromosome 1 as demonstrated by in situ hybridization with 5S ribosomal RNA Human Genetics. 36: 25-33. PMID 870409 DOI: 10.1007/BF00390432  0.88
Show low-probability matches.